Ikena Oncology (NASDAQ:IKNA – Get Rating) is one of 254 public companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare Ikena Oncology to related businesses based on the strength of its profitability, analyst recommendations, risk, earnings, institutional ownership, dividends and valuation. Valuation & Earnings This […]